REGN

Regeneron Pharmaceuticals

D

REGN

USD

8.505

(1.0417%)

Market Closed

22,903.00

Volume

44.6215

EPS

-

Div Yield

21.841

P/E

90,937,974,698.55

Market Cap

Today

1.0417%

1 Week

-1.560%

1 Month

-17.194%

6 Months

-14.992%

12 Months

-0.741%

Year To Date

-6.151%

All Time

0%

Related Instruments

Title:
Regeneron Pharmaceuticals

Sector:

Healthcare

Industry:

Biotechnology

Regeneron Pharmaceuticals Inc. is an integrated biotechnology firm. The company was founded in 1988 and is headquartered in Tarrytown, New York. It develops, manufactures and sells medicines for serious conditions such as eye diseases, allergy and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic conditions, infectious diseases and more. Its product line includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST and ZALTRAP. The company was founded by Alfred G. Gilman, Leonard S. Schleifer and Eric M. Shooter on January 8, 1988.

Do you need help or have a question?